<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03704870</url>
  </required_header>
  <id_info>
    <org_study_id>17-5398</org_study_id>
    <nct_id>NCT03704870</nct_id>
  </id_info>
  <brief_title>Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection</brief_title>
  <official_title>A Randomized Controlled Feasibility Study Looking at Differences in Hospital Stay Variables Following Omission of Daily Routine Chest Radiographs After Pulmonary Resection.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, it is the standard of care practice to perform daily routine CXR when a chest tube
      is in situ following pulmonary resection. However, previous research as well as experience of
      thoracic surgeons suggested this kind of management has poor diagnostic and therapeutic
      value. Eliminating daily routine CXR for adult patients having undergone pulmonary surgery
      might decrease the frequency of radiation exposure and hospitalization costs per patient
      without increasing reintervention rates, length of hospital stays, readmission rates or any
      adverse events.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 26, 2018</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of total chest xrays performed per subject</measure>
    <time_frame>30 days</time_frame>
    <description>number of scheduled and additional chest xrays, and how does this correlate with post operative safety</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Lung Diseases</condition>
  <condition>Lung Cancer, Nonsmall Cell</condition>
  <condition>Surgery</condition>
  <condition>Lung Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>Daily Chest Xray (standard)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Chest Xray post chest tube removal only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Chest Xray</intervention_name>
    <description>Daily chest xray</description>
    <arm_group_label>Daily Chest Xray (standard)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>No daily chest xray</intervention_name>
    <description>Chest xray will be done post chest tube removal only</description>
    <arm_group_label>Chest Xray post chest tube removal only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult males or females who plan to receive VATS pulmonary resections confined to
             lobectomies, segmentectomies and wedge resections.

          -  Willingness to adhere to randomized treatment.

          -  Ability to answer self- and interviewer- administered questions in English

          -  Understand and sign a written informed consent form in English

        Exclusion Criteria:

          -  Previous thoracic surgery history in the same side.

          -  Exploration, biopsy, lung volume reduction surgeries (LVRS), bilobectomies, sleeve
             resections or pneumonectomies performed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gail Darling, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UHN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>February 28, 2018</study_first_submitted>
  <study_first_submitted_qc>October 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2018</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Adenocarcinoma of Lung</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

